Navigation Links
Neuropathic Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:9/20/2011

tics – Promising Drugs Under Clinical Development 56

5.6 Molecule Profile for Promising Drugs under Clinical Development 57

5.6.1 AVP-923 (Zenvia) 57

5.6.2 Fentora (fentanyl buccal tablet) 58

5.6.3 Nucynta ER (tapentadol) 59

5.6.4 AS-3201 (ranirestat) 60

5.7 Key Takeaway 61

6 Neuropathic Pain Therapeutics: Clinical Trials Mapping 62

6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 62

6.2 Clinical Trials by Phase 63

6.3 Clinical Trials by Trial Status 64

6.4 Clinical Trials by Sponsors 65

6.5 Top Companies Participating in Neuropathic Pain Therapeutics Clinical Trials 67

7 Neuropathic Pain Therapeutics - Strategic Assessment 68

7.1 Key Events Impacting the Future Market 68

7.2 Neuropathic Pain Therapeutics: Implications for Future Market Competition 69

8 Neuropathic Pain Therapeutics - Future Players 71

8.1 Introduction 71

8.2 Company Profiles 72

8.2.1 Pfizer Inc. 72

8.2.2 Grunenthal GmbH 76

8.2.3 Avanir Pharmaceuticals 78

8.2.4 Cephalon Inc. 79

8.2.5 Endo Pharmaceuticals 82

8.2.6 Dainippon Sumitomo Pharma Co., Ltd. 84

8.2.7 NeurogesX Inc. 88

8.2.8 Other Companies in the Neuropathic Pain Therapeutics Market 91

9 Neuropathic Pain Therapeutics - Licensing and Partnership Deals 99

10 Neuropathic Pain Therapeutics - Appendix 106

10.1 Market Definitions 106

10.2 Abbreviations 106

10.3 Research Methodology 107

10.3.1 Coverage 108

10.3.2 Secondary Research 108

10.3.3 Forecasting 108

10.3.4 Primary Research 111

10.3.5 Expert Panel Validation 111

10.4 Contact Us 111

10.5 Disclaimer 111

10.6 Bibliography 112

List of Tables

Table 1: Differentiation of Chronic Pain from Acute Pain 7

Table 2: Neuropathic Pain Therapeutics Market, Global, Revenue ($bn), 2005–2010 1
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
2. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
3. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
4. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
5. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
6. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
7. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
8. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., ... therapeutics, including those with rare and orphan inflammatory disease ... the U.S. Food and Drug Administration (FDA) to begin ... candidate, acebilustat (CTX-4430), in adult CF patients in the ... Europe will be filed soon ...
(Date:7/6/2015)... FRANCISCO, Calif. , July 6, 2015 ... pharmaceutical company, and Oculeve, a development-stage medical device company ... today announced that they have entered into an agreement ... transaction.  Under the terms of the agreement, Allergan will ... commercialization milestone payments related to Oculeve,s lead development program ...
(Date:7/6/2015)... , July 6, 2015 China Information Technology, Inc. ... provider of integrated cloud-based platform, exchange, and big data ... that the Company launched its mobile app for Healthcare ... healthcare services on mobile devices. The Company jointly hosted ... Family Planning Bureau and Shenzhen News Net.   ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... Naviscan, Inc., the worldwide leader in 3D Molecular ... PhD has joined the Naviscan Board of Directors. ... related to reimbursement in the medical device industry.  He ... Reimbursement at Acclarent, Inc.  After acquisition by Ethicon, Inc., ...
... Calif., July 14, 2011 Molecular Devices, LLC, ... & development, life science research, and bioassay/test development, ... Accreditation (A2LA) has accredited the Laboratory Quality System ... re-calibration processes. (Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ...
Cached Medicine Technology:Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation 2
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain is ... located in the neck. Another 19% suffer from head, migraine, or facial pain, in ... that 45% of American workers must deal with neck pain. Strategies for ...
(Date:7/3/2015)... ... , ... The Harvest Hope Food Bank will hopefully be getting a large donation ... in the area of Greenville SC are making it their mission to collect as many ... are asking for donations from the public as well. As part of the canned food ...
(Date:7/3/2015)... ... July 03, 2015 , ... Rheumatology ... 2015 Annual Conference , the premiere continuing education and networking event for ... SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in immunology, ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... Western society are suffering from auto-immune diseases. Discovering the ... step in the search for targeted medicines. VIB researchers ... joined forces and have elucidated the function of MALT1, ... are the first to show that MALT1 is able ...
... rumi regulates Notch signaling by adding a glucose molecule ... outside a cell, said researchers from Baylor College of ... York in a report that appears today in the ... protein determines cell fate determination and differentiation. , ...
... Comment, ROLLING MEADOWS, Ill., Jan. 26 ... member specialty,organization of leaders in the field of ... the petition filed by Public Citizen with the,U.S. ... The ASDS supports the current labeling of all ...
... 25 The,American Society of Plastic Surgeons (ASPS) ... products and adverse events following,a recent petition from ... Citizen requested the U.S. Food and Drug,Administration (FDA) ... More than one million people have been ...
... Costs have climbed 32% since 2002, study finds ... and economic costs in the United States hit $174 ... a new study shows. , The research, commissioned by ... for people with diabetes were about $116 billion, and ...
... attempt to end own life, study finds , , FRIDAY, Jan. 25 ... likely to attempt suicide and more than twice as likely to ... study says. , Violent suicide includes hanging, the use of a ... of a vehicle, or drowning. , The increased risk of suicide ...
Cached Medicine News:Health News:A major step toward a more targeted treatment for auto-immune diseases? 2Health News:Notch-ing glucose into place 2Health News:American Society for Dermatologic Surgery Supports Current Labeling of Allergan's Botox(R) Products 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2Health News:Diabetes' Health Toll Hits $174 Billion Annually 2Health News:Short Birth Length Boosts Men's Suicide Risk 2
9 mm wide tip. Designated most popular model or size....
4 mm wide tip. Designated most popular model or size....
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: